The growing interest in Targeted Radionuclide Therapy (TRT) is driving research across nuclear medicine, radiochemistry, radiopharmacy, radiotherapy, biology, and physics. However, a lack of standardization in preclinical radiobiological studies on amongst other nomenclature and report makes it challenging to compare results across laboratories.
7 recommendations to improve reproducibility, comparability, and visibility in preclinical TRT research are provided in the recently published article Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy | European Journal of Nuclear Medicine and Molecular Imaging
